Immunome, Inc. (IMNM) Profit Margins
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IMNMImmunome, Inc.Follow IMNM — free
—
Price chart with a free account
- Market cap
- 2.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 22 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Operating margin | -781.4% | -3382.4% | -3228.8% | — | |
| Net margin | -761.9% | -3240.4% | -3060.0% | — | |
| FCF margin | -59.9% | -1304.8% | -2890.1% | — |
USD millions · SEC XBRL
Every figure on this page comes from Immunome, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.